Federal award (DELIVERY ORDER, fiscal year 2021)
Recipient: LEIDOS BIOMEDICAL RESEARCH INC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2018-09-28 to 2023-09-27
Current total value of award: $19812417
Description: RARE AND RECALCITRANT CANCERS FOR ESTABLISHING THE PREDICTIVE POWER OF PATIENT-DERIVED XENOGRAFTS (PDXS)